{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:14:17Z","timestamp":1754162057753,"version":"3.41.2"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Vildagliptin, an oral antidiabetic of the dipeptidyl peptidase-4 (DPP-4) inhibitor drugs, exhibits an overall low risk of hypoglycemia with less frequent hypoglycemic events in type 2 diabetes mellitus (T2DM) patients than other antidiabetic drugs. We hypothesized that among hospitalized acute coronary syndrome (ACS) patients, the addition of vildagliptin to subcutaneous insulin therapy would reduce the risk of hypoglycemic events.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>One hundred ACS T2DM adult patients naive to DPP-4 inhibitors were enrolled during admission to the ICCU. Patients were divided into two randomized controlled groups: a subcutaneous rapid-acting insulin-only therapy group and an oral vildagliptin plus subcutaneous insulin group. The trial was open label with no placebo arm. Mean glucose values, insulin values given for correction per hospitalization, and the number of hypoglycemic events (glucose\u2009&lt;\u200970\u2009mg\/dL) were documented.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Eight hypoglycemia events occurred in the insulin-only group and none in the insulin plus DPP-4 inhibitor group (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2009&lt;\u20090.001). Patients with acute myocardial infarction experienced a higher number of hypoglycemic events compared with unstable angina diagnosed patients. No significant differences were found regarding glucose level (<jats:italic toggle=\"yes\">P\u2009<\/jats:italic>=\u20090.462) and administered insulin units (<jats:italic toggle=\"yes\">P\u2009<\/jats:italic>=\u20090.639).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>In T2DM patients, the addition of DPP-4 inhibitors to routine subcutaneous insulin therapy may significantly reduce hypoglycemic events while maintaining acceptable recommended ranges of glucose. Further studies on a larger scale are required to verify these results and to support that DPP-4 inhibitors added to today\u2019s standard insulin-only treatment in hospitalized diabetic ACS patients may improve overall glycemic control and provide a potential treatment option in this challenging clinical setting.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mca.0000000000000901","type":"journal-article","created":{"date-parts":[[2020,4,19]],"date-time":"2020-04-19T19:58:43Z","timestamp":1587326323000},"page":"4-9","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Vildagliptin vs. insulin treatment alone in diabetic acute coronary syndrome patients"],"prefix":"10.1097","volume":"32","author":[{"given":"Idit","family":"Dobrecky-Mery","sequence":"first","affiliation":[{"name":"Department of Cardiology, Bnai-Zion Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adir","family":"Sommer","sequence":"additional","affiliation":[{"name":"The Ruth and Bruce Rappaport Faculty of Medicine, Technion \u2013 Israel Institute of Technology, Haifa, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,4,16]]},"reference":[{"key":"R3-20250729","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1136\/hrt.2006.112656","article-title":"Mortality after myocardial infarction in patients with diabetes mellitus.","volume":"93","author":"Kapur","year":"2007","journal-title":"Heart"},{"key":"R4-20250729","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM199807233390404","article-title":"Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.","volume":"339","author":"Haffner","year":"1998","journal-title":"N Engl J Med"},{"key":"R5-20250729","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1001\/archinte.164.13.1457","article-title":"Implications of diabetes in patients with acute coronary syndromes. The global registry of acute coronary events.","volume":"164","author":"Franklin","year":"2004","journal-title":"Arch Intern Med"},{"key":"R6-20250729","first-page":"e344","article-title":"2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines.","volume":"130","author":"Amsterdam","year":"2014","journal-title":"Circulation"},{"key":"R7-20250729","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1001\/jama.2009.496","article-title":"Relationship between spontaneous and iatrogenic hypoglycemia and mortality in patients hospitalized with acute myocardial infarction.","volume":"301","author":"Kosiborod","year":"2009","journal-title":"JAMA"},{"key":"R8-20250729","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s13300-014-0082-y","article-title":"Higher risk of hypoglycemia with glimepiride versus vildagliptin in patients with type 2 diabetes is not driven by high doses of glimepiride: divergent patient susceptibilities?","volume":"5","author":"Ahr\u00e9n","year":"2014","journal-title":"Diabetes Ther"},{"key":"R9-20250729","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s13300-010-0018-0","article-title":"Minimizing the risk of hypoglycemia with vildagliptin: clinical experience, mechanistic basis, and importance in type 2 diabetes management.","volume":"2","author":"Dejager","year":"2011","journal-title":"Diabetes Ther"},{"key":"R10-20250729","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/jdi.12764","article-title":"Addition of dipeptidyl peptidase-4 inhibitors to insulin treatment in type 2 diabetes patients: a meta-analysis.","volume":"9","author":"Yang","year":"2018","journal-title":"J Diabetes Investig"},{"key":"R11-20250729","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1007\/s13300-018-0488-z","article-title":"Safety and efficacy of DPP4 inhibitor and basal insulin in type 2 diabetes: an updated review and challenging clinical scenarios.","volume":"9","author":"Gomez-Peralta","year":"2018","journal-title":"Diabetes Ther"},{"key":"R13-20250729","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1007\/s00134-009-1585-2","article-title":"A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study.","volume":"35","author":"Preiser","year":"2009","journal-title":"Intensive Care Med"},{"key":"R14-20250729","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1378\/chest.06-3121","article-title":"Tight blood glucose control with insulin in the ICU: facts and controversies.","volume":"132","author":"Vanhorebeek","year":"2007","journal-title":"Chest"},{"key":"R15-20250729","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1097\/01.CCM.0000282073.98414.4B","article-title":"Severe hypoglycemia in critically ill patients: risk factors and outcomes.","volume":"35","author":"Krinsley","year":"2007","journal-title":"Crit Care Med"},{"key":"R16-20250729","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1097\/CCM.0b013e31818781f5","article-title":"Intensive care unit hypoglycemia predicts depression during early recovery from acute lung injury.","volume":"36","author":"Dowdy","year":"2008","journal-title":"Crit Care Med"},{"key":"R17-20250729","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12887-015-0403-y","article-title":"U-shaped relationship between early blood glucose and mortality in critically ill children.","volume":"15","author":"Li","year":"2015","journal-title":"BMC Pediatr"},{"key":"R18-20250729","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1097\/CCM.0b013e3181de562c","article-title":"Hypoglycemia is associated with intensive care unit mortality.","volume":"38","author":"Hermanides","year":"2010","journal-title":"Crit Care Med"},{"key":"R19-20250729","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1056\/NEJMoa0810625","article-title":"Intensive versus conventional glucose control in critically ill patients.","volume":"360","author":"Finfer","year":"2009","journal-title":"N Engl J Med"},{"key":"R20-20250729","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1056\/NEJMoa1204942","article-title":"Hypoglycemia and risk of death in critically ill patients.","volume":"367","author":"Finfer","year":"2012","journal-title":"N Engl J Med"},{"key":"R21-20250729","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jacc.2005.03.052","article-title":"U-shaped relationship of blood glucose with adverse outcomes among patients with ST-segment elevation myocardial infarction.","volume":"46","author":"Pinto","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R22-20250729","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/eurheartj\/ehi230","article-title":"Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events.","volume":"26","author":"Svensson","year":"2005","journal-title":"Eur Heart J"}],"container-title":["Coronary Artery Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000000901","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T18:07:02Z","timestamp":1753812422000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000000901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,16]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/mca.0000000000000901","relation":{},"ISSN":["0954-6928"],"issn-type":[{"type":"print","value":"0954-6928"}],"subject":[],"published":{"date-parts":[[2020,4,16]]}}}